THE GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH LTD

Their core work

The Gertner Institute is an Israeli applied health research centre specialising in epidemiology, health policy analysis, and digital health interventions. Their work bridges clinical research and real-world health system decision-making — they study how populations use and benefit from healthcare, and how policy can be designed to improve outcomes. In H2020, they contributed to mobile mental health technology (m-RESIST) and European-scale research on informal caregiving and eHealth policy (ENTWINE), signalling a dual competence in digital therapeutic tools and care system policy. They function as a specialist scientific partner that brings population-level evidence and policy translation skills to multi-country health research consortia.

What they specialise in

How they've shifted over time

Gertner's H2020 trajectory shows a deliberate shift from acute digital clinical applications toward broader social and policy dimensions of health. Their early work (m-RESIST, 2015–2017) was centred on technology-aided treatment for a specific psychiatric condition, with no recorded policy or social care keywords. By their second project (ENTWINE, 2018–2023), the focus had moved to informal caregiving, eHealth enablement, and health policy — broader societal health challenges rather than individual clinical interventions. This suggests the institute is repositioning toward health systems research and care policy at the European level.

Gertner is moving toward European health policy and digital care systems research, making them an increasingly relevant partner for projects addressing caregiver burden, ageing populations, and health system reform.

How they like to work

Gertner participates exclusively as a non-leading partner — they have no coordinator credits across their H2020 portfolio. They integrate into large international consortia (37 unique partners across 10 countries over just two projects) as a specialist contributor rather than a project driver. This pattern suggests they are most valuable when a consortium needs credible epidemiological expertise or health policy grounding, and that working with them means engaging a focused scientific team rather than a project management hub.

Gertner has built a surprisingly wide network for a two-project participant — 37 unique consortium partners across 10 countries. Their reach is European in scope despite being based in Israel, reflecting the cross-border nature of both mental health and informal care research consortia they joined.

What sets them apart

Gertner is one of few Israeli research institutes with a track record in both EU digital health projects and European care policy research, giving them a non-EU perspective that can strengthen consortium diversity requirements. Their combination of epidemiological methodology and health policy translation is relatively rare — most health research partners offer one or the other. For consortia targeting Horizon Europe's health cluster, Gertner provides scientifically credible, policy-oriented expertise with an established record of working within large European partnerships.

Highlights from their portfolio

• m-RESIST
  Gertner's largest funded project (€532,875) addressed one of psychiatry's hardest problems — treatment-resistant schizophrenia — through mobile therapeutic technology, demonstrating capacity in both digital health and serious mental illness research.
• ENTWINE
  A five-year MSCA Training Network on informal care across Europe, this project signals Gertner's entry into care systems and social health policy — a growing priority area in EU health research funding.